Strong cash flow at Becton Dickinson allows buy-back of 10 million shares:
This article was originally published in Clinica
Executive Summary
Drugs and diagnostics company BD (Becton Dickinson) is to repurchase up to 10 million shares, which it plans to use for general corporate purposes. As of March 31 2007, the firm had around 245 million shares outstanding. The authorisation of the share buy-back reflects the company's strong cash flow, said Franklin Lakes, New Jersey-based BD. Steris